G1 Therapeutics Inc (GTHX) Return on Investment ROI from the second quarter of 2024 to second quarter of 2023 and for the year 2024, average high and low, overall ranking from Jun 30 2024 to Jun 30 2023 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
G1 Therapeutics Inc   (NASDAQ: GTHX)


G1 Therapeutics Inc's ROI from its second quarter of 2024 to the second quarter of 2023 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is G1 Therapeutics Inc's ROI in the second quarter of 2024?
G1 Therapeutics Inc recorded a cumulative net loss of $-45 million during 12 months ending in the second quarter of 2024, resulting in a negative return on investment (ROI) of -55.64%.

Within the Healthcare sector 601 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2024 from 2906 to 4107.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter
Y / Y Investment Change TTM -38.58 % -33.06 % -29.48 % -28.27 % -32.47 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 61 69 92 99 114
Return On Investment (TTM) -55.64 % -32.66 % -44.26 % -57.27 % -59.39 %
GTHX's Overall Ranking # 4107 # 2906 # 1887 # 3791 # 1045
Seq. Investment Change TTM -14.09 % -13.57 % -12.26 % -5.72 % -6.37 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -45 -31 -48 -71 -78

GTHX Company Profile >> Back to GTHX Roi Comparisons >> See Annual GTHX Return On Investment



Return On Investment GTHX's Ranking
Within: No.
Industry # 261
Sector # 602
Overall # 4107

Return On Investment Statistics
High Average Low
-28.31 %
-54.61 %
-96.02 %
(Mar 31 2019)   (Dec 31 2022)







Financial Statements
G1 Therapeutics Inc's II. Quarter Investments $ 61 Millions GTHX's Balance sheet
G1 Therapeutics Inc's II. Quarter Income $ -5 Millions Quarterly GTHX's Income Statement
GTHX's Income by Division See GTHX's Income by Division


GTHX Annual Return On Investment (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019
Total Investments in Millions 92 152 226 205 265
Y / Y Investment Growth -39.74 % -32.72 % 10.42 % -22.62 % -26.15 %
Net Income in Millions -48 -148 -148 -99 -122
Y / Y Net Income Growth - - - - -
Annual Return On Investment -52.24 % -96.84 % -65.5 % -48.39 % -46.2 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
GTHX's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for GTHX's Competitors
Subscribers only: Roi for G1 Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for GTHX's Customers

Other Ratios
GTHX's Roa GTHX's Inventory Turnover Ratio GTHX's Growth Rates GTHX's Dividend Statistics
GTHX's Profitability Ratios GTHX's Asset Turnover Ratio GTHX's Dividend Growth
GTHX's Roe GTHX's Valuation Ratios GTHX's Financial Strength Ratios GTHX's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2024, within Healthcare Sector ROI

Date modified: 2026-09-18T13:11:05+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.